← Leaderboards
Michael S Lipkowitz
Mount Sinai School Of Medicine Of Nyu
$2,401,149
Attributed
$2,401,149
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $227K · FY2005–08$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$2,401,149 · 5
By mechanism
R01$1,852,685 · 1
R21$472,663 · 1
M01$75,801 · 3
Top collaborators
No co-investigators on record.
Most similar at Mount Sinai School Of Medicine Of Nyu
Same institution · by research overlap
- Paul Evan Klotman$9,745,988
- Michael J Ross$6,839,251
- Ali G Gharavi$45,808,576
- Karina W. Davidson$51,701,923
- Srinivas Ravi V Iyengar$36,509,089
Others in their field
Top investigators on “African American”
- Daniel C Ralph · Cornell University$89,901,072
- Roger T Howe · University Of California-Berkeley$89,901,072
- James D Crapo · University Of Colorado Denver$80,593,932
- Laurence H Baker · University Of Michigan At Ann Arbor$80,299,268
- William J. Blot · Vanderbilt University$71,101,682
- Sid E O'Bryant · University Of North Texas Hlth Sci Ctr$70,204,880
Research focus
African AmericanHuman SubjectClinical ResearchKidney FunctionLinkage DisequilibriumsGenetic PolymorphismRenin Angiotensin SystemHypersensitivityLipoprotein LipaseAdrenergic ReceptorHuman Population GeneticsKidney DisorderDisease /Disorder EtiologySerumCollectionCohort StudiesCardiovascular SystemCohortEnrollmentClinical TrialsCardiovascular DiseasesEnd Stage Renal FailureEconomic FactorsDisease Progression
Grant awards (10)
THE AASK COHORT STUDY$12,555
M01 · FY2008 · RR · contact PI
THE AASK COHORT STUDY$40,726
M01 · FY2007 · RR · contact PI
THE AASK COHORT STUDY$22,520
M01 · FY2006 · RR · contact PI
Proteomic Predictors Of AASK Renal Disease Progression$226,976
R21 · FY2005 · DK
ETIOLOGY OF NEPHROPATHY AND HYPERTENSION IN AASK PATIENT$381,375
R01 · FY2004 · DK
Proteomic Predictors Of AASK Renal Disease Progression$245,687
R21 · FY2004 · DK
ETIOLOGY OF NEPHROPATHY AND HYPERTENSION IN AASK PATIENT$381,375
R01 · FY2003 · DK
ETIOLOGY OF NEPHROPATHY AND HYPERTENSION IN AASK PATIENT$339,000
R01 · FY2002 · DK
ETIOLOGY OF NEPHROPATHY AND HYPERTENSION IN AASK PATIENT$381,375
R01 · FY2001 · DK
ETIOLOGY OF NEPHROPATHY AND HYPERTENSION IN AASK PATIENT$369,560
R01 · FY2000 · DK